Hsbc Holdings PLC Purchases 19,788 Shares of Envista Holdings Corporation $NVST

Hsbc Holdings PLC raised its position in shares of Envista Holdings Corporation (NYSE:NVST) by 31.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 83,350 shares of the company’s stock after buying an additional 19,788 shares during the quarter. Hsbc Holdings PLC owned about 0.05% of Envista worth $1,821,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of NVST. Caitong International Asset Management Co. Ltd increased its stake in shares of Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares in the last quarter. Allworth Financial LP lifted its position in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares during the period. UMB Bank n.a. boosted its stake in Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after acquiring an additional 636 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares in the last quarter. Finally, IFP Advisors Inc grew its holdings in Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after purchasing an additional 1,071 shares during the period.

Envista Trading Up 0.0%

Shares of NYSE:NVST opened at $26.97 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42. The company has a market cap of $4.39 billion, a P/E ratio of 65.78, a PEG ratio of 1.53 and a beta of 0.88. The stock’s fifty day moving average price is $24.88 and its 200-day moving average price is $25.15.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million during the quarter, compared to the consensus estimate of $680.03 million. During the same period last year, the company earned $0.24 EPS. Envista’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Sell-side analysts expect that Envista Holdings Corporation will post 1.42 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on NVST shares. Robert W. Baird raised their target price on shares of Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Evercore restated an “outperform” rating and issued a $33.00 price target on shares of Envista in a research note on Thursday, May 7th. Barclays reduced their price objective on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, June 11th. Finally, Citigroup started coverage on Envista in a research note on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $28.67.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.